Ligand validation:4RDH

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 4RDH designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4RDH_AMP_C_301	100%	23%	0.039	0.983	1.37	1.79	3	6	0	0	100%	1
4RDH_AMP_A_301	99%	24%	0.044	0.979	1.32	1.77	2	5	0	0	100%	1
4RDH_AMP_B_301	99%	20%	0.047	0.976	1.37	1.99	4	9	0	0	100%	1
4RDH_AMP_D_301	98%	19%	0.053	0.971	1.24	2.18	1	7	0	0	100%	1
4YED_AMP_C_301	92%	27%	0.074	0.963	1.22	1.7	3	6	0	0	100%	1
4D7A_AMP_D_401	80%	46%	0.094	0.944	0.81	1.27	-	2	0	0	100%	1
3LOQ_AMP_A_271	100%	45%	0.039	0.987	0.82	1.3	-	2	2	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
3FWZ_AMP_B_601	100%	32%	0.037	0.984	1.15	1.55	2	4	0	0	100%	1
3CLT_AMP_C_1262	100%	40%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1
5VEO_AMP_A_524	100%	40%	0.046	0.987	0.86	1.47	-	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.